Search / 6 results found

from
to

MONDAY, Jan. 24, 2022 (healthDay News) -- The U.S. Food and Drug Administration said Monday that it will curtail the use of two monoclonal antibody treatments that do not appear to work against the highly contagious Omicron variant.

  • Updated

MONDAY, Jan. 24, 2022 (healthDay News) -- The U.S. Food and Drug Administration may soon curtail the use of two monoclonal antibody treatments that do not appear to work against the highly contagious Omicron variant.

  • Updated

WEDNESDAY, Jan. 19, 2022 (HealthDay News) -- The U.S. Food and Drug Administration approved Rinvoq (upadacitinib) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older, the manufacturer announced Friday.